Quantinuum’s (QNT) “Buy” Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities reaffirmed their buy rating on shares of Quantinuum (NASDAQ:QNT) in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a $155.00 target price on the stock.

A number of other research analysts also recently issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price target on shares of Quantinuum in a report on Wednesday. Jefferies Financial Group set a $85.00 price objective on Quantinuum in a research note on Wednesday. TD Cowen began coverage on Quantinuum in a research report on Monday, June 29th. They set a “buy” rating on the stock. Morgan Stanley initiated coverage on Quantinuum in a research note on Monday, June 29th. They issued an “equal weight” rating and a $78.00 target price on the stock. Finally, Wall Street Zen downgraded shares of Quantinuum from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $98.42.

Quantinuum Stock Performance

NASDAQ QNT opened at $63.58 on Wednesday. The company’s 50 day simple moving average is $63.20. Quantinuum has a 52-week low of $47.06 and a 52-week high of $86.79.

Quantinuum (NASDAQ:QNT) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The company had revenue of $8.00 million for the quarter. On average, equities analysts predict that Quantinuum will post -1.6 earnings per share for the current year.

Insider Buying and Selling at Quantinuum

In other Quantinuum news, Director Manish H. Bhatia purchased 20,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $60.00 per share, for a total transaction of $1,200,000.00. Following the completion of the purchase, the director owned 25,833 shares of the company’s stock, valued at approximately $1,549,980. The trade was a 342.88% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Michal Stepniak acquired 13,333 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were bought at an average price of $60.00 per share, for a total transaction of $799,980.00. Following the acquisition, the director owned 13,333 shares of the company’s stock, valued at approximately $799,980. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have bought 411,032 shares of company stock valued at $24,661,920.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC acquired a new position in shares of Quantinuum Inc. (NASDAQ:QNT) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 5,005 shares of the company’s stock, valued at approximately $409,000.

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.